Latest Partnerships News

Cobre Limited has landed a $4 million strategic investment from Tribeca Investment Partners to accelerate development of its Ngami In-Situ Copper Recovery project in Botswana, marking a key step toward commercialising this promising copper resource.

Streamplay Studio’s Winter Burrow has quickly generated over A$1.8 million in revenue days after its global release, driven by strong sales on Steam, Nintendo Switch, and Xbox Game Pass installs.

Terragen Holdings has secured a major purchase order from Mort & Co Fertilisers for its Great Land Plus® bio-stimulant, projecting a significant sales boost in 2026. This deal underscores growing demand for sustainable agricultural solutions.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Genmin Limited has launched a A$25.7 million equity raising to advance its Baniaka iron ore project in Gabon, aiming for a final investment decision by mid-2026. The raise includes strategic collaboration with PowerChina and offers attaching options to investors.

BPH Global Ltd has reported a record-breaking month in its Indonesian seaweed operations, more than doubling previous sales and advancing its export capabilities.

Locksley Resources has partnered with Columbia University to develop cutting-edge, sustainable technologies for rare earth and critical mineral processing in the US, advancing its Mine-to-Market strategy amid growing government support.

Aurora Labs has entered a strategic MOU with Ares Armaments to co-develop advanced metal components for defence, aiming to revolutionise small-arms manufacturing with additive technology.

AnteoTech has achieved a breakthrough with its Ultranode™ X anode surpassing 1,000 charge cycles at 80% capacity retention, meeting key benchmarks for electric vehicle and eVTOL batteries. This milestone leverages cost-effective silicon materials, promising to reshape supply chains and accelerate market adoption.

Island Pharmaceuticals has secured FDA confirmation that its antiviral Galidesivir can proceed under the Animal Rule pathway for Marburg virus, qualifying for a lucrative Priority Review Voucher. This regulatory milestone accelerates the drug’s path to approval and potential government stockpile inclusion.

Syrah Resources has secured an $8.5 million tranche from its US DFC loan, deferred interest payments to mid-2026, and issued warrants to the DFC, reinforcing the strategic importance of its Balama graphite operation.

Syrah Resources has secured an extension to address an alleged default under its Tesla offtake agreement, pushing the cure deadline to January 2026 while continuing negotiations.